SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-612789
Filing Date
2016-06-03
Accepted
2016-06-03 17:11:18
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d200935ds3.htm S-3 283341
2 EX-4.1 d200935dex41.htm EX-4.1 314645
3 EX-4.2 d200935dex42.htm EX-4.2 312050
4 EX-5.1 d200935dex51.htm EX-5.1 17009
5 EX-5.2 d200935dex52.htm EX-5.2 29387
6 EX-23.1 d200935dex231.htm EX-23.1 3719
7 GRAPHIC g200935g14m32.jpg GRAPHIC 3131
8 GRAPHIC g200935g39r79.jpg GRAPHIC 3595
  Complete submission text file 0001193125-16-612789.txt   970793
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-211844 | Film No.: 161696629
SIC: 8731 Services-Commercial Physical & Biological Research